Drug Profile
PN 27,1
Alternative Names: AndroCarLatest Information Update: 27 Aug 2002
Price :
$50
*
At a glance
- Originator Paracelsian
- Class Antineoplastics; Antiplatelets
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Coronary artery restenosis
- Discontinued Cancer
Most Recent Events
- 27 Aug 2002 Discontinued - Clinical-Phase-Unknown for Cancer in USA (PO)
- 08 Dec 1998 No-Development-Reported for Coronary artery restenosis in USA (Unknown route)
- 03 Sep 1998 Profile reviewed